Growth Metrics

Supernus Pharmaceuticals (SUPN) Other Working Capital Changes (2016 - 2026)

Supernus Pharmaceuticals has reported Other Working Capital Changes over the past 15 years, most recently at $6.9 million for Q4 2025.

  • Quarterly Other Working Capital Changes fell 36.12% to $6.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.2 million through Dec 2025, down 31.9% year-over-year, with the annual reading at $13.2 million for FY2025, 31.9% down from the prior year.
  • Other Working Capital Changes was $6.9 million for Q4 2025 at Supernus Pharmaceuticals, down from $11.1 million in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $28.2 million in Q2 2023 and troughed at -$20.4 million in Q3 2023.
  • The 5-year median for Other Working Capital Changes is -$728000.0 (2024), against an average of $935882.4.
  • The largest YoY upside for Other Working Capital Changes was 3603.48% in 2023 against a maximum downside of 1556.33% in 2023.
  • A 5-year view of Other Working Capital Changes shows it stood at -$4.7 million in 2021, then plummeted by 97.87% to -$9.2 million in 2022, then grew by 15.22% to -$7.8 million in 2023, then skyrocketed by 238.52% to $10.8 million in 2024, then tumbled by 36.12% to $6.9 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Other Working Capital Changes are $6.9 million (Q4 2025), $11.1 million (Q3 2025), and $2.5 million (Q2 2025).